TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35349378

Group type: EXPERIMENTAL
Intervention: Hormone contraceptives
Number of subjects: 0

Group type: COMPARATOR
Intervention: Naturally cycling women
Number of subjects: 0
Study: 34016410

Group type: EXPERIMENTAL
Intervention: Ranger drug‐coated balloon (DCB) (paclitaxel dose density 2 μg/mm2)
Number of subjects: 376

Group type: COMPARATOR
Intervention: Standard percutaneous transluminal angioplasty (PTA)
Number of subjects: 376

Group type: EXPERIMENTAL
Intervention: Ranger drug‐coated balloon (DCB)
Number of subjects: 376
Study: 32882390

Group type: EXPERIMENTAL
Intervention: Upstream administration of ticagrelor before angiography
Number of subjects: 1449

Group type: COMPARATOR
Intervention: Downstream administration of ticagrelor or prasugrel after angiography
Number of subjects: 1449
Study: 35091845

Group type: EXPERIMENTAL
Intervention: Pharmacist-led pharmaceutical care program
Number of subjects: 115

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 115
Study: 33407845

Group type: EXPERIMENTAL
Intervention: Nitrous oxide/oxygen mixture
Number of subjects: 42

Group type: COMPARATOR
Intervention: Routine treatment plus oxygen (Control)
Number of subjects: 42
Study: 34344494

Group type: EXPERIMENTAL
Intervention: Edoxaban
Number of subjects: 150

Group type: COMPARATOR
Intervention: Standard of care (vitamin K antagonist and low molecular weight heparin)
Number of subjects: 150
Study: 34283841

Group type: EXPERIMENTAL
Intervention: Iron-containing micronutrient powder (12.5 mg of iron daily)
Number of subjects: 871

Group type: COMPARATOR
Intervention: Placebo (micronutrient powder without iron)
Number of subjects: 871

Group type: EXPERIMENTAL
Intervention: Iron-containing micronutrient powder (among iron-sufficient or iron-replete children)
Number of subjects: 871

Group type: EXPERIMENTAL
Intervention: Children with sufficient iron status
Number of subjects: 871
Study: 32193740

Group type: EXPERIMENTAL
Intervention: Patients with Type 2 Diabetes Mellitus (T2DM)
Number of subjects: 188

Group type: COMPARATOR
Intervention: Patients without Type 2 Diabetes Mellitus (non-T2DM)
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Patients with Type 2 Diabetes Mellitus (T2DM) with pathologic acid reflux
Number of subjects: 188
Study: 34174859

Group type: EXPERIMENTAL
Intervention: Percutaneous curved kyphoplasty (PCKP)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Bilateral percutaneous kyphoplasty (PKP)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Both PCKP and PKP
Number of subjects: 72
Study: 33162797

Group type: EXPERIMENTAL
Intervention: FFP3 filtering respirators
Number of subjects: 78

Group type: COMPARATOR
Intervention: Surgical masks
Number of subjects: 78
Study: 35537786

Group type: EXPERIMENTAL
Intervention: Regimen-DI (doxorubicin 6×75 mg/m2/week; cisplatin 6×100 mg/m2/week every 2 weeks)
Number of subjects: 497

Group type: COMPARATOR
Intervention: Regimen-C (doxorubicin 6×75 mg/m2/week; cisplatin 6×100 mg/m2/week every 3 weeks)
Number of subjects: 497

Group type: EXPERIMENTAL
Intervention: Intensified regimen (compared to control)
Number of subjects: 497

Group type: EXPERIMENTAL
Intervention: Histological response
Number of subjects: 497
Study: 32843424

Group type: EXPERIMENTAL
Intervention: Moderate calorie restriction
Number of subjects: 0
Study: 34075630

Group type: EXPERIMENTAL
Intervention: onabotulinumtoxinA 200 units
Number of subjects: 21

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: onabotulinumtoxinA
Number of subjects: 21
Study: 33726637

Group type: EXPERIMENTAL
Intervention: Senior Mentor Program (SMP)
Number of subjects: 102
Study: 34475094

Group type: EXPERIMENTAL
Intervention: Preoperative serum levels of carcinoembryonic antigen (CEA)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Preoperative serum levels of cyclin‐dependent kinase regulatory subunit 2 (CKS2)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Preoperative serum levels of 2'‐5'‐oligoadenylate synthetase 2 (OAS2)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Preoperative serum levels of autophagy‐related gene 5 (ATG5)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Combination of serum CEA, CKS2, OAS2, and ATG5
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: ROC analysis of biomarkers
Number of subjects: 120
Study: 35381765

Group type: EXPERIMENTAL
Intervention: Albumin adjusted ischemia-modified albumin (AdjIMA)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Total antioxidant status (TAS)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Ischemia modified albumin (IMA)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Body mass index (BMI)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Waist-hip ratio (WHR)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Blood pressure (BP) parameters
Number of subjects: 40
Study: 33355484

Group type: EXPERIMENTAL
Intervention: GP-Lis25
Number of subjects: 210

Group type: COMPARATOR
Intervention: Ly-Lis25 (Humalog Mix 25)
Number of subjects: 210
Study: 35570477

Group type: EXPERIMENTAL
Intervention: Dry needling (DN)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Dry needling with needle retention
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (not applicable)
Number of subjects: 54
Study: 32856406

Group type: COMPARATOR
Intervention: Nurses with less clinical experience
Number of subjects: 1113

Group type: EXPERIMENTAL
Intervention: Nurses with more clinical experience
Number of subjects: 1113

Group type: EXPERIMENTAL
Intervention: Nurses with varying clinical experience
Number of subjects: 1113

Group type: EXPERIMENTAL
Intervention: Nurses with more experience
Number of subjects: 1113

Group type: EXPERIMENTAL
Intervention: Nurses' perceptions of the need for specific skills
Number of subjects: 1113
Study: 35843124

Group type: EXPERIMENTAL
Intervention: HIIT
Number of subjects: 23

Group type: COMPARATOR
Intervention: MICT
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Combined HIIT and MICT
Number of subjects: 23
Study: 32469454

Group type: EXPERIMENTAL
Intervention: PCIT-ED (Parent-Child Interaction Therapy Emotion Development)
Number of subjects: 229

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 229
Study: 36384543

Group type: EXPERIMENTAL
Intervention: Simple sutures with 4-0 vicryl threads
Number of subjects: 32

Group type: COMPARATOR
Intervention: Cross-mattress sutures with 4-0 vicryl threads
Number of subjects: 32
Study: 32068928

Group type: EXPERIMENTAL
Intervention: Fetal Endoscopic Tracheal Occlusion (FETO)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Expectant management
Number of subjects: 50
Study: 35510723

Group type: EXPERIMENTAL
Intervention: Tablet personal computer distraction (animated video played during IV placement)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (no tablet distraction)
Number of subjects: 22
Study: 33780086

Group type: EXPERIMENTAL
Intervention: Paced Auditory Serial Addition Test (PASAT; cognitive effort; n=32)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Resting state (n=33)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Paced Auditory Serial Addition Test (PASAT) under time pressure (n=29)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Paced Auditory Serial Addition Test (PASAT) with social-evaluative threat (video camera; n=29)
Number of subjects: 38
Study: 33675755

Group type: EXPERIMENTAL
Intervention: Monthly pegcetacoplan (15 mg)
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Every other month (EOM) pegcetacoplan (15 mg)
Number of subjects: 192

Group type: COMPARATOR
Intervention: Sham injection
Number of subjects: 192
Study: 32179871

Group type: COMPARATOR
Intervention: Congenital gastrointestinal surgical conditions (CGISCs)
Number of subjects: 37
Study: 36028873

Group type: EXPERIMENTAL
Intervention: Internal Facilitation (IF)
Number of subjects: 7030

Group type: EXPERIMENTAL
Intervention: Internal Facilitation (IF) + External Facilitation (EF)
Number of subjects: 7030
Study: 33313731

Group type: EXPERIMENTAL
Intervention: SBIRT-PM
Number of subjects: 1100

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1100
Study: 32620300

Group type: EXPERIMENTAL
Intervention: Using the Patient Concerns Inventory (PCI) package in clinic
Number of subjects: 67

Group type: COMPARATOR
Intervention: Not using the Patient Concerns Inventory (PCI) package in clinic
Number of subjects: 67
Study: 35304745

Group type: EXPERIMENTAL
Intervention: 12-hour magnesium sulfate regimen
Number of subjects: 1176
Study: 34881663

Group type: EXPERIMENTAL
Intervention: Thinking Healthy Programme Peer‐delivered (THPP)
Number of subjects: 0
Study: 35115017

Group type: EXPERIMENTAL
Intervention: Smoking cessation services in LAC-LACDHS-operated outpatient primary care clinics and LAC-LACDMH-operated community mental health clinics
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Treatment as usual in clinics
Number of subjects: 1200
Study: 34819058

Group type: COMPARATOR
Intervention: CHTC as usual
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: CHTC plus CT video
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: CHTC plus SUM
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: CHTC plus CT video + SUM
Number of subjects: 2
Study: 36048348

Group type: EXPERIMENTAL
Intervention: 1 mg of daily injectable vitamin B12
Number of subjects: 72

Group type: COMPARATOR
Intervention: 1 mg of daily injectable vitamin B12 with other multinutrients (B12 + MV)
Number of subjects: 72
Study: 34717169

Group type: EXPERIMENTAL
Intervention: Single set of acute care scenarios
Number of subjects: 146

Group type: COMPARATOR
Intervention: Double set of acute care scenarios
Number of subjects: 146
Study: 33360642

Group type: EXPERIMENTAL
Intervention: Personalised exercise programme (12-week duration, including balance, endurance, strength, and flexibility training)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Personalised exercise programme
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group (normal daily activities)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 14
Study: 32493052

Group type: EXPERIMENTAL
Intervention: Intravenous continuous infusion (CI) of midazolam
Number of subjects: 99

Group type: COMPARATOR
Intervention: Intravenous intermittent bolus (IB) doses of midazolam
Number of subjects: 99
Study: 36197264

Group type: EXPERIMENTAL
Intervention: Medication combined with schedule exercise therapy (MSET)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Medication (MED)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: All subjects combined
Number of subjects: 118
Study: 34117276

Group type: EXPERIMENTAL
Intervention: Endurance training
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Endurance-strength training
Number of subjects: 101
Study: 32358086

Group type: EXPERIMENTAL
Intervention: 177Lu-EB-PSMA 2.12 ± 0.19 GBq (Group B)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: 177Lu-EB-PSMA 3.52 ± 0.58 GBq (Group C)
Number of subjects: 28

Group type: COMPARATOR
Intervention: 177Lu-EB-PSMA 1.18 ± 0.09 GBq (Group A)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: 177Lu-EB-PSMA (all groups)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: 177Lu-EB-PSMA (Group B and C)
Number of subjects: 28
Study: 35576129

Group type: EXPERIMENTAL
Intervention: FMS Group (coaching the Australian recommended fundamental overarm throwing skill criteria)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Sports Group (skilled sports-active pupils)
Number of subjects: 97
Study: 36418536

Group type: EXPERIMENTAL
Intervention: Active device emitting UVB light (peak wavelength of 285 nm)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Sham device emitting visible light
Number of subjects: 136
Study: 33667155

Group type: EXPERIMENTAL
Intervention: Nursing interventions based on Dennis's Breastfeeding Self‐Efficacy Theory and Pender's Health Promotion Model during home visits
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Nursing interventions
Number of subjects: 60
Study: 32272181

Group type: EXPERIMENTAL
Intervention: Thymoquinone (TQ) combined with arsenic/interferon-alpha (As/IFN-α)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Arsenic/interferon-alpha (As/IFN-α)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Thymoquinone (TQ) alone or in combination
Number of subjects: 4
Study: 33579652

Group type: EXPERIMENTAL
Intervention: 4‐mo Mediterranean diet and moderate physical activity program
Number of subjects: 263

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 263
Study: 33709982

Group type: EXPERIMENTAL
Intervention: Intensive blood pressure (BP) control
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Antihypertensive therapies
Number of subjects: 0

Group type: COMPARATOR
Intervention: Current BP targets
Number of subjects: 0
Study: 32951743

Group type: EXPERIMENTAL
Intervention: δ‐tocotrienol 300 mg twice daily
Number of subjects: 71

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 71
Study: 35774629

Group type: EXPERIMENTAL
Intervention: Dynamic scapular recognition exercise with vertical downward correction using rigid taping (50% to 75% tension)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Dynamic scapular recognition exercise with sham taping
Number of subjects: 67
Study: 33392754

Group type: EXPERIMENTAL
Intervention: Fibula tunnel drilling during PLC reconstruction
Number of subjects: 101
Study: 33413489

Group type: EXPERIMENTAL
Intervention: PRECIS-2-PS tool
Number of subjects: 0
Study: 32619630

Group type: EXPERIMENTAL
Intervention: Self-rehabilitation program (8 weeks duration)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Self-rehabilitation program
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 59
Study: 33070253

Group type: EXPERIMENTAL
Intervention: Denosumab (specific antibody to human RANKL)
Number of subjects: 0
Study: 36130764

Group type: EXPERIMENTAL
Intervention: Better WASH practices
Number of subjects: 193576

Group type: COMPARATOR
Intervention: Not better WASH practices
Number of subjects: 193576
Study: 32929721

Group type: EXPERIMENTAL
Intervention: Endoseal MTA
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: EndoSequence BC Sealer
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: AH Plus
Number of subjects: 90
Study: 32942053

Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Waitlist control (standard care for 16 weeks)
Number of subjects: 180
Study: 34662890

Group type: EXPERIMENTAL
Intervention: Apixaban (2.5 mg twice daily, later increased to 5 mg twice daily)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Warfarin (target international normalized ratio 2-3)
Number of subjects: 48
Study: 33400618

Group type: EXPERIMENTAL
Intervention: Controlled-balanced energy availability without exercise (BAL; 45 kcal·kg LBM-1·day-1)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Exercise-induced low energy availability (EX; 15 kcal·kg LBM-1·day-1, including 30 kcal·kg LBM-1·day-1 treadmill running at 70% maximal oxygen uptake)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Diet-induced low energy availability (DIET; 15 kcal·kg LBM-1·day-1)
Number of subjects: 20
Study: 36326770

Group type: EXPERIMENTAL
Intervention: Low-intensity transcutaneous electrical stimulation of the right auricular branch (25 Hz, 50 mA) for 20 minutes prior to anesthesia
Number of subjects: 134

Group type: COMPARATOR
Intervention: Control group (no stimulation)
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Low-intensity transcutaneous electrical stimulation of the right auricular branch
Number of subjects: 134
Study: 34444833

Group type: EXPERIMENTAL
Intervention: Coach-directed weight loss (behavioral telephonic coaching)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Metformin (up to 2000 mg daily)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Self-directed weight loss (informational brochures)
Number of subjects: 121
Study: 32611451

Group type: EXPERIMENTAL
Intervention: High intensity, high frequency peer reminders (monthly)
Number of subjects: 349

Group type: COMPARATOR
Intervention: Quarterly peer reminders
Number of subjects: 349

Group type: COMPARATOR
Intervention: Monthly paper-based reminders
Number of subjects: 349

Group type: COMPARATOR
Intervention: Quarterly paper-based reminders
Number of subjects: 349
Study: 35620782

Group type: EXPERIMENTAL
Intervention: Transcranial Direct Current Stimulation (tDCS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 0
Study: 36056721

Group type: EXPERIMENTAL
Intervention: SAA-reduced formula diet (LowS group)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Regular formula diet (control group)
Number of subjects: 115
Study: 32179696

Group type: EXPERIMENTAL
Intervention: Vaginal assisted laparoscopic radical hysterectomy (VALRH)
Number of subjects: 389

Group type: COMPARATOR
Intervention: Open abdominal radical hysterectomy
Number of subjects: 389
Study: 33234670

Group type: EXPERIMENTAL
Intervention: Green Mediterranean diet
Number of subjects: 294

Group type: EXPERIMENTAL
Intervention: Mediterranean diet
Number of subjects: 294

Group type: COMPARATOR
Intervention: Healthy dietary guidance (HDG)
Number of subjects: 294
Study: 32000828

Group type: EXPERIMENTAL
Intervention: 100 mg aspirin for 6 months after index ERBD
Number of subjects: 184

Group type: COMPARATOR
Intervention: Placebo for 6 months after index ERBD
Number of subjects: 184
Study: 35443676

Group type: EXPERIMENTAL
Intervention: DF-HA 30 mg
Number of subjects: 290

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 290
Study: 33367782

Group type: EXPERIMENTAL
Intervention: Ketone monoester (KME) drink containing 12 g β‐OHB
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 33484897

Group type: EXPERIMENTAL
Intervention: Educational and Empowerment (E2) intervention with Post‐Acute Care Hypertension Consultation (PACHT‐c) and mobile health BP self‐monitoring kit
Number of subjects: 770

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 770

Group type: EXPERIMENTAL
Intervention: Educational and Empowerment (E2) intervention
Number of subjects: 770
Study: 34738243

Group type: EXPERIMENTAL
Intervention: Intervention (structured curricula, play materials, nutrition, training and supervision)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Intervention
Number of subjects: 110
Study: 32376326

Group type: EXPERIMENTAL
Intervention: Home-based video game exercises (60 minutes, 3 times per week for 8 weeks)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Home-based video game exercises
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (maintain usual levels of activity and care seeking behaviors)
Number of subjects: 60
Study: 36219198

Group type: EXPERIMENTAL
Intervention: Furocyst® (2 capsules of 500 mg/day)
Number of subjects: 208

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 208
Study: 33946212

Group type: EXPERIMENTAL
Intervention: Mixed tree nuts (MTNs)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Refined carbohydrate pretzel snack (PS)
Number of subjects: 95
Study: 35440463

Group type: EXPERIMENTAL
Intervention: Fit-For-Fertility Programme (FFFP) for 6 months, then in combination with usual care for infertility if not pregnant; intervention duration up to 18 months or 24 months if pregnant.
Number of subjects: 616

Group type: COMPARATOR
Intervention: Usual fertility care (control arm).
Number of subjects: 616

Group type: EXPERIMENTAL
Intervention: FFFP and usual care for infertility if not pregnant.
Number of subjects: 616
Study: 33571950

Group type: EXPERIMENTAL
Intervention: Nortriptyline
Number of subjects: 205

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 205
Study: 33936396

Group type: EXPERIMENTAL
Intervention: Deep learning model (Bi-LSTM-CRF) for extracting eligibility criteria
Number of subjects: 100
Study: 34331930

Group type: EXPERIMENTAL
Intervention: Sublingual sufentanil cartridges (Zalviso)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Intravenous pain management (Control)
Number of subjects: 80
Study: 33870785

Group type: EXPERIMENTAL
Intervention: Home-based Pilates (twice-weekly, guided by a DVD)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 80
Study: 32810055

Group type: EXPERIMENTAL
Intervention: Standard PA curriculum plus EBM training
Number of subjects: 61

Group type: COMPARATOR
Intervention: Standard PA curriculum only
Number of subjects: 61
Study: 33864068

Group type: EXPERIMENTAL
Intervention: Physical Activity (PA) levels of 500-999 MET-min/week
Number of subjects: 465

Group type: EXPERIMENTAL
Intervention: Physical Activity (PA) levels of 2000+ MET-min/week
Number of subjects: 465

Group type: EXPERIMENTAL
Intervention: Achieving at least 90 MET-min/week of PA
Number of subjects: 465

Group type: EXPERIMENTAL
Intervention: Physical Activity (PA)
Number of subjects: 465

Group type: EXPERIMENTAL
Intervention: High NFL levels
Number of subjects: 465
Study: 32087597

Group type: EXPERIMENTAL
Intervention: Tape applied from muscle origin to insertion (facilitation)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Tape applied from muscle insertion to origin (inhibition)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Baseline (without tape)
Number of subjects: 27
Study: 34374633

Group type: EXPERIMENTAL
Intervention: six 20-minute sessions of moderate-intensity walking
Number of subjects: 44

Group type: COMPARATOR
Intervention: assessment-only control
Number of subjects: 44
Study: 33667420

Group type: EXPERIMENTAL
Intervention: R-MegaCHOEP (high-dose chemotherapy plus rituximab followed by autologous HSCT)
Number of subjects: 275

Group type: COMPARATOR
Intervention: R-CHOEP-14 (conventional chemotherapy plus rituximab)
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: R-MegaCHOEP
Number of subjects: 275

Group type: COMPARATOR
Intervention: R-CHOEP-14
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 275
Study: 35859288

Group type: EXPERIMENTAL
Intervention: Core stabilization exercises in addition to traditional scoliosis exercises for 8 weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: Traditional scoliosis exercises for 8 weeks
Number of subjects: 30
Study: 33333147

Group type: EXPERIMENTAL
Intervention: eGFR variability
Number of subjects: 7520
Study: 33429762

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 0.2 μg/kg/hour (group D1)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 0.4 μg/kg/hour (group D2)
Number of subjects: 90

Group type: COMPARATOR
Intervention: 0.9% saline 0.2 μg/kg/hour (group C)
Number of subjects: 90
Study: 32470201

Group type: EXPERIMENTAL
Intervention: Screening for type 2 diabetes mellitus
Number of subjects: 20184